NEU 2.71% $19.70 neuren pharmaceuticals limited

I initially thought the same way as you Good1234. But I still...

  1. 100 Posts.
    lightbulb Created with Sketch. 43
    I initially thought the same way as you Good1234. But I still think that there was very little interest in Trof and that's why our upfront was so low and why nothing ever came of the leerink appointment. I could never understand why Acadia would trigger their exclusive negotiations period prior to phase 3. I don't think there is another company sniffing around. I think our low share price is an opportune time for Acadia to secure ROW cheaply whilst expectations are low given current market price.
    It may be the right time for Acadia to take over the company for the same reasons.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.70
Change
0.520(2.71%)
Mkt cap ! $2.515B
Open High Low Value Volume
$19.39 $19.84 $19.28 $5.675M 288.6K

Buyers (Bids)

No. Vol. Price($)
3 1531 $19.66
 

Sellers (Offers)

Price($) Vol. No.
$19.81 557 1
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
$19.70
  Change
0.520 ( 2.59 %)
Open High Low Volume
$19.50 $19.84 $19.28 87628
Last updated 15.59pm 03/05/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.